Literature DB >> 3036497

Development of a monoclonal antibody specific for serotype 3 rotavirus strains.

B Grunert, H J Streckert, W Liedtke, C Houly, C Mietens, H Werchau.   

Abstract

Monoclonal antibodies were prepared against serotype 3 simian rotavirus SA11. Antigenic analysis of 18 hybridoma cell lines secreting monoclonal antibodies by radioimmunoprecipitation and Western blot revealed that seven monoclonals were directed against the major inner capsid protein VP6, four against VP3, an outer capsid protein with hemagglutinating activity, and one against VP7, the main outer capsid protein of the virus. The specificity of six monoclonals could not be determined. One monoclonal (1P14E2) directed against VP3 showed serotype 3-specific neutralizing activity. This monoclonal, which recognized only serotype 3 viruses in an enzyme-linked immunosorbent assay, could be useful in assays for serotyping rotavirus directly in stool samples.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036497     DOI: 10.1007/BF02018194

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  39 in total

1.  Epidemiology of human rotavirus Types 1 and 2 as studied by enzyme-linked immunosorbent assay.

Authors:  R H Yolken; R G Wyatt; G Zissis; C D Brandt; W J Rodriguez; H W Kim; R H Parrott; J J Urrutia; L Mata; H B Greenberg; A Z Kapikian; R M Chanock
Journal:  N Engl J Med       Date:  1978-11-23       Impact factor: 91.245

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  The major surface glycoprotein of simian rotavirus (SA11) contains distinct epitopes.

Authors:  S Sonza; A M Breschkin; I H Holmes
Journal:  Virology       Date:  1984-04-30       Impact factor: 3.616

4.  Nomenclature of human rotaviruses: designation of subgroups and serotypes.

Authors: 
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

5.  Characterization of anti-reovirus immunoglobulins secreted by cloned hybridoma cell lines.

Authors:  P W Lee; E C Hayes; W K Joklik
Journal:  Virology       Date:  1981-01-15       Impact factor: 3.616

6.  Antibodies specific for the carboxy-terminal region of the major surface glycoprotein of simian rotavirus (SA11) and human rotavirus (Wa).

Authors:  H J Streckert; B Grunert; H Werchau
Journal:  J Cell Biochem       Date:  1986       Impact factor: 4.429

7.  Identification of the two rotavirus genes determining neutralization specificities.

Authors:  P A Offit; G Blavat
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

8.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

9.  Changes in the antigenicity of the hemagglutinin molecule of H3 influenza virus at acidic pH.

Authors:  R G Webster; L E Brown; D C Jackson
Journal:  Virology       Date:  1983-04-30       Impact factor: 3.616

10.  Rotavirus and other viral diarrhoeas: WHO scientific working group.

Authors: 
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

View more
  3 in total

1.  A synthetic peptide corresponding to the cleavage region of VP3 from rotavirus SA11 induces neutralizing antibodies.

Authors:  H J Streckert; H Brüssow; H Werchau
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

2.  Polypeptide specificity of antiviral serum antibodies in children naturally infected with human rotavirus.

Authors:  H Brüssow; P A Offit; G Gerna; A Bruttin; J Sidoti
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

3.  Monoclonal antipeptide antibodies recognize epitopes upon VP4 and VP7 of simian rotavirus SA11 in infected MA104 cells.

Authors:  G Hansen; F Mehnert; H J Streckert; H Werchau
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.